Quick Takeaways
- TORONTO DOMINION BANK filed SCHEDULE 13G for Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK).
- Disclosed ownership: 5.8%.
- Date of event: 30 Sep 2025.
TORONTO DOMINION BANK - 30 Sep 2025 SCHEDULE 13G Report for Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK)
- Filing Manager
- TORONTO DOMINION BANK
- Reporting Manager
- The Toronto-Dominion Bank
- Symbol
- STOK
- Shares outstanding
- 54,711,345 shares
- Disclosed Ownership
- 3,173,258 shares
- Ownership
- 5.8%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Nov 2025, 11:24:15 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"TORONTO DOMINION BANK disclosed 5.8% ownership in Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 11:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Toronto-Dominion Bank | 5.8% | 3,173,258 | 3,173,258 | 0 | Christina Petrou | Christina Petrou / Executive Vice President & Chief Operating Officer |